Conference Day One
Wednesday, May 7
8:20 am Registration & Light Breakfast
9:20 am Chair’s Opening Remarks
Leveraging AI & Automation to Revolutionize Financial Planning in Life Sciences to Give Company-wide Clarity on Accurate FP&A
9:30 am Discover: Uncovering AI-Powered Efficiency for Better Use of Labour- Intensive Time
Synopsis
• How to shift toward reducing manual effort in tasks such as data entry, reporting, and complex spreadsheet management
• Exploring the better use of time for the FP&A professional on high-value activities such as strategic decision-making and scenario analysis
• How to streamline workflows to achieve more in less time with a quickly adapting climate of biopharma
9:50 am Discover: Addressing the Challenges in The Adoption of AI Based Programs for Streamlined Transitions
Synopsis
• How to manage cultural shifts as teams transition into a more AI-powered process
• How to build trust in the value of AI for stakeholders by using small steps toward automation and gradual establishing of confidence in AI
• How to ensure that your data is ready for AI using clean, high-quality data for the most reliable output
10:10 am Develop What More Can We Learn From FP&A Professions on The Use and Adaptation to AI?
Synopsis
• With AI on the forefront of everyone’s minds, how can we prepare for how this may change FP&A and be adapted to across the biopharma space?
A Q&A session facilitated by the chair
10:30 am Action: How Could we Adapt to AI in Our Companies, and Have The Opinions We Had Previously Formed On AI Changed?
Synopsis
Output Focused Action Session Facilitated by the Chair
10:50 am Morning Break & Speed Networking
Synopsis
Our speed networking is the ideal opportunity to get face-to-face time with many of the brightest minds working in FP&A and introduce yourself to the attendees that you would like to build closer working relationships with. Benchmark against the industry leaders and establish meaningful business relationships to pursue for the rest of the conference and beyond.
Revolutionizing The Spreadsheet and Deciphering the Best Tools for Use In FP&A To Create the Most Effective Complex Models
11:50 am Fireside chat: Exploring Methods to Decide Which Tools Will Work Best For Your Company To Align to Your Objectives
Synopsis
• How to assess a new tool to decipher if it is the right fit for your company
• How to approach transitioning to new tools so that FP&A is not disrupted
• How to assess a new tool via a demo so that you are confident in a tool’s capabilities
12:40 pm Action: How Are We Going to Assess The Tools We Use Against The Needs Of The Company?
Synopsis
Output Focused Action Session Facilitated by the Chair
1:00 pm Lunch & Networking
Understanding The Business of a Biopharma as a Financial Professional to Allow for Deeper Insights into Analysis & Modelling
1:50 pm Discover: Delving Deeper Beyond the Numbers and Understanding the Biopharma Business to Build More Accurate Models
Synopsis
• How to incorporate probabilities of clinical success, regulatory approvals, and market uptake into biopharma financial models
• Exploring the critical scientific knowledge needed from a finance professional to understand how to model clinical projects
• How to train and upskill new financial professionals in the world of biopharma so that the finance team understands the context for modeling
2:10 pm Discover: Building On the Knowledge of Biopharma to Improve Financial Modelling Accuracy and Delivery Throughout the Business
Synopsis
• How to use scientific insights when delivering and presenting data so it is best understood by senior stakeholders
• Developing scenarios in collaboration with scientific teams to provide more accurate possibilities within models
• Working with clinical team/functional heads to improve the accuracy and delivery of FP&A insights to key stakeholders
2:30 pm Develop What More Can we Learn From The FP&A Leaders on the Importance of Understanding Biopharma?
Synopsis
• In an industry where research and development are the drivers, how can we best understand this to adapt our FP&A?
A Q&A session facilitated by the chair
2:50 pm Action: What are we Going to do Differently Now to Insure we are Understanding the Science Behind the Business?
Synopsis
Output Focused Action Session Facilitated by the Chair
3:10 pm Afternoon Break & Netowrking
Optimizing The Forecast for The Unpredictability of a Clinical Trial to Have Better Insight into The Financial Uncertainty
3:40 pm Discover: Navigating The Strategies for The Effective Budgeting of Clinical Trials to Cover as Many Outcomes as Possible
Synopsis
• How to manage budget changes, track detailed expenses, and adapt to the dynamic nature of a trial
• How to anticipate costs in a volatile cash environment of the clinical trial
• Navigating the essential role of budget tracking and collaboration with cross-functional teams for accuracy
4:00 pm Discover: Essential Focus Areas to Immediately Improve Your Clinical Trials Budgeting & Forecasting Processes
Synopsis
• Identifying and tracking the most significant variables driving budget variances
• Forecasting outsourcing versus FTE expense allocations
• Effectively managing Clinical’s relentless changes and overexuberance
4:20 pm Develop What More can we Learn from FP&A Leaders About Budgeting for Clinical Trials?
Synopsis
• Clinical trials can be demanding and volatile in cost and outcomes, so the ability to best prepare for this is key
A Q&A session facilitated by the chair
4:40 pm Action: What Actions Will We Take When Budgeting for Future Trials?
Synopsis
Output Focused Action Session Facilitated by the Chair